Siemens Healthineers AG Stock News

Data Bridge Market Research analyses that the digital health monitoring devices market will exhibit a CAGR of around 18.37% for the forecast period of 2021-2028. Rising prevalence of neurological disorders, increased focus on research and development proficiencies in regards to

Siemens Healthineers (ETR:SHL) has been assigned a 75.00 ($85.23) target price by equities research analysts at Berenberg Bank in a research report issued to clients and investors on Tuesday, Borsen Zeitung reports. Berenberg Banks price objective indicates a potential upside of 18.18% from the companys current price. Several other research analysts also recently commented on []

Siemens Healthineers (ETR: SHL) recently received a number of ratings updates from brokerages and research firms: 11/23/2021 Siemens Healthineers was given a new 75.00 ($85.23) price target on by analysts at Berenberg Bank. 11/23/2021 Siemens Healthineers was given a new 62.00 ($70.45) price target on by analysts at Jefferies Financial Group Inc.. 11/19/2021 []

Pre-owned Medical Devices Market Comprehensive Study is an expert and top to bottom investigation on the momentum condition of the worldwide Pre-owned Medical Devices industry with an attention on the Global market. The report gives key insights available status of

Berenberg Bank reiterated their buy rating on shares of Siemens Healthineers (OTCMKTS:SMMNY) in a research report sent to investors on Tuesday morning, The Fly reports. SMMNY has been the topic of a number of other research reports. Credit Suisse Group reaffirmed an outperform rating on shares of Siemens Healthineers in a research note on Thursday, []

The ASEAN and North Asian Point of Care/Rapid Diagnostics Market study analyzes the market status, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors, and Porter''s Five Forces Analysis. This research report encompasses

Veterinary Ultrasound Market research analysis and data lend a hand to businesses for the planning of production, product launches, costing, inventory, purchasing, and marketing strategies. The company profiles of all the chief and dominating market players and brands who are

Shares of Siemens Healthineers AG (ETR:SHL) have been assigned an average rating of Hold from the fourteen brokerages that are currently covering the stock, MarketBeat.com reports. Three analysts have rated the stock with a hold rating and one has issued a buy rating on the company. The average 12-month target price among brokers that have []

Major cancer diagnostics market players include Abbott, Biocartis, Becton, Dickinson and Company, Janssen Diagnostic LLC, GE Healthcare, Siemens Healthineers, and Sysmex Corporation. Major cancer diagnostics market players include Abbott, Biocartis, Becton, Dickinson and Company, Janssen Diagnostic LLC, GE Healthcare, Siemens Healthineers, and Sysmex Corporation.

Deutsche Bank Aktiengesellschaft initiated coverage on shares of Siemens Healthineers (OTCMKTS:SEMHF) in a research report released on Thursday, TipRanks reports. The firm issued a buy rating and a $74.00 target price on the stock. Separately, Societe Generale lowered shares of Siemens Healthineers to a hold rating and set a $60.30 target price on the stock. []

The global Microfluidics Device market was valued at 5667.88 Million USD in 2020 and will grow with a CAGR of 15.36% from 2021 to 2027. Microfluidic devices are in high demand due to their ability to significantly lower the cost

The global Computed Tomography (CT) market was valued at 4353.41 Million USD in 2020 and will grow with a CAGR of 3.42% from 2021 to 2027. Globally, healthcare spending per capita is increasing. People''s ability and willingness to invest in

Deutsche Bank Aktiengesellschaft began coverage on shares of Siemens Healthineers (OTCMKTS:SEMHF) in a research report sent to investors on Thursday, TipRanks reports. The brokerage issued a buy rating and a $74.00 price target on the stock. Separately, Societe Generale cut Siemens Healthineers to a hold rating and set a $60.30 target price for the company. []

Dublin, Nov. 19, 2021 (GLOBE NEWSWIRE) -- The "Global Mammography Market Size, Share & Trends Analysis Report by Product (Film Screen Systems, Digital Systems, Analog Systems, Biopsy Systems, 3D Systems), by Technology, by Application, by Region, and Segment Forecasts, 2021-2028" report has been added to ResearchAndMarkets.com''s offering. The global mammography market size is expected to reach a value of USD 3.8 billion by 2028, expanding at a CAGR of 10% from 2021 to 2028.

Barclays set a 54.00 ($63.53) target price on Siemens Healthineers (ETR:SHL) in a report issued on Tuesday morning, Borsen Zeitung reports. A number of other analysts have also recently issued reports on SHL. UBS Group set a 54.00 ($63.53) price objective on Siemens Healthineers in a report on Friday, November 5th. Kepler Capital Markets set []